Dairy and snacking brand Epigamia, operated by Drums Food International, has completed a secondary share transaction worth approximately $20 million. Existing backer Verlinvest and the family of late cofounder Rohan Mirchandani increased their ownership, while Sauce.vc joined the cap table. The transaction involved the purchase of shares from existing investors and did not inject fresh capital into the company.
Cap Table Consolidation
The deal enabled early investors DSG Consumer Partners and Deepika Padukone's investment firm KA Enterprises to secure profitable exits by selling a portion of their stakes. Other angel investors also participated as sellers in the secondary transaction. Epigamia chief executive officer Ritesh Gauba described the development as a strong endorsement of the business and the opportunity ahead.
Verlinvest first backed the startup in 2016 and has participated in multiple funding rounds since then. Arjun Anand, managing director and head of Asia at Verlinvest, said the decision reflected conviction in the brand's potential and leadership. Sauce founder Manu Chandra noted that his association dates back to a personal angel investment in 2014, when the company was called Hokey Pokey.
Market Position and Product Portfolio
Epigamia began as a Greek yoghurt brand and has expanded into artisanal curd, snack packs, protein milkshakes, smoothies, and lactose-free products. Greek yoghurt continues to drive more than half of the company's revenue. The brand sells through its own website, quick commerce platforms, ecommerce channels, and offline retail stores.
Epigamia services over 150 cities in India and has a distribution network spanning more than 25,000 retail touchpoints. Quick commerce contributes between 50 and 60 percent of monthly revenues, while offline channels account for around 40 percent. The company has recently focused on strengthening its backend operations and expanding manufacturing capacity.
Leadership and Financial Trajectory
Ritesh Gauba took over as chief executive officer in May 2025 and brings more than 24 years of FMCG experience from companies including Mars and Britannia. Around the same time, chief operating officer Ankur Goel was elevated to cofounder. Rohan Mirchandani passed away in December 2024, and the leadership team has since worked to maintain operational continuity.
For fiscal 2024, Epigamia's net loss declined nearly 74 percent to ₹17.4 crore from ₹67 crore a year earlier. Operating revenue rose 3.3 percent to ₹173.7 crore from ₹168.1 crore during the same period. The company, which is yet to file its financial statements for fiscal 2025, said it is now profitable and cash-rich with no immediate funding requirement.
Growth Outlook
Epigamia aims to exit the current financial year at an annual recurring revenue of more than ₹700 crore and reach over ₹1,000 crore by fiscal 2028. It expects to double its business every 24 to 30 months through innovations and stronger operations. The secondary transaction is expected to provide a stable shareholder base for this next phase of growth.
The consolidation of Epigamia's cap table reflects growing investor confidence in the brand's profitability and expansion potential. With long-term backers increasing their stakes and a new institutional investor joining, the company is positioned to pursue its health-focused product agenda. The transaction provides liquidity to early supporters while aligning ownership for the company's next growth chapter.